Promega Madison Earns ISO 14001 Environmental Certification
Promega Corporation on May 6th, announced that its headquarters in Madison, Wisconsin, has achieved ISO 14001:2015 certification, an internationally recognized standard for environmental management systems. This certification reflects the biotechnology manufacturer’s longstanding commitment to environmental stewardship and sustainability. “For more than 45 years, Promega has been dedicated to environmental management and sustainable practices within the life […]
François Ravenelle, PhD, Appointed CEO of Innospera Pharma to Lead Growth Strategy
Innospera Pharma Inc. (“Innospera”), a private, near-clinical-stage biotechnology company focused on developing small-molecule modulators of GPR84 and GPR40 to address a broad range of inflammatory and metabolic diseases with high unmet medical needs, on May 6th announced the appointment of François Ravenelle, PhD, as President and Chief Executive Officer, effective immediately. Dr. Ravenelle is an accomplished biotech leader with […]
2025 Economic Outlook: Key Insights for Investors
With 2025 already here, the global economy continues to evolve, presenting a mix of challenges and opportunities for investors. Navigating this dynamic landscape requires a keen understanding of key trends and market drivers. Here are three critical areas to focus on: 1. Global Interest Rates and Investment Strategies Central banks worldwide are adjusting their monetary […]
DunhamTrimmer Appoints Ignacio Moyano Cordoba as VP of Business Development for LATAM
DunhamTrimmer, a global leader in business intelligence for the biocontrol, biostimulant, biofertilizer, and specialized nutrition industries, announced the addition of Ignacio Moyano Córdoba as Vice President of Business Development for Latin America. With more than 20 years of experience in the agricultural sector, Ignacio has held strategic positions such as General Manager of Stoller Brazil, […]
Veracyte Announces Appointment of Brent Shafer and Tom Miller, Ph.D., to Its Board
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, recently announced the appointment of Brent Shafer and Tom Miller, Ph.D., to its board of directors, effective immediately. “We are thrilled to welcome Brent and Tom to our board,” said Marc Stapley, Veracyte’s chief executive officer. “They are both seasoned business leaders with extensive healthcare industry […]
Maryland Tech Council and BIOQuébec collaborate to promote life sciences
BIOQuébec and the Maryland Tech Council (MTC) are delighted to announce a new Memorandum of Understanding (MOU) that will enhance cooperation and collaboration between life sciences sectors in Québec and Maryland. This partnership aims to foster mutual benefits and strengthen biopharma and biotech industries in both regions through shared information and opportunities. The MOU establishes […]
Merck Signs MoU with KAIST to Further Scientific Partnership in South Korea
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST). The academia-industry cooperation aims to advance the research and development ecosystem in South Korea for industrial applications. “Our collaboration with KAIST is an important step towards accelerating the biotechnology ramp-up […]
Cognivia announces strategic EUR 15.5Mln funding
Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, announced a significant investment milestone. Vesalius Biocapital IV, SFPIM (Société Fédérale de Participations et d’Investissement) and WE (Wallonie Entreprendre) have committed strategic investments to drive Cognivia’s mission to “quantify the power of the mind” to optimize and […]
Kenai Therapeutics announces USD 82Mln series A financing
Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders, today announced an $82 million Series A financing co-led by Alaska Permanent Fund Corporation, Cure Ventures and The Column Group, with participation from Euclidean Capital and Saisei Ventures. […]
STEMCELL Technologies to acquire all assets of SQZ Biotechnologies Company
STEMCELL Technologies announced the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders today, marks another significant milestone for STEMCELL, Canada’s […]